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Abstract
Background: Hypospadias is a relatively common birth defect affecting the male urinary tract. It has been suggested
that exposure to endocrine disrupting chemicals might increase the risk of hypospadias by interrupting normal urethral
development.
Methods: Using data from the National Birth Defects Prevention Study, a population-based case-control study, we
considered the role of maternal exposure to atrazine, a widely used herbicide and potential endocrine disruptor, via
drinking water in the etiology of 2nd and 3rd degree hypospadias. We used data on 343 hypospadias cases and
1,422 male controls in North Carolina, Arkansas, Iowa, and Texas from 1998–2005. Using catchment level stream and
groundwater contaminant models from the US Geological Survey, we estimated atrazine concentrations in public
water supplies and in private wells. We assigned case and control mothers to public water supplies based on
geocoded maternal address during the critical window of exposure for hypospadias (i.e., gestational weeks 6–16).
Using maternal questionnaire data about water consumption and drinking water, we estimated a surrogate for total
maternal consumption of atrazine via drinking water. We then included additional maternal covariates, including age,
race/ethnicity, parity, and plurality, in logistic regression analyses to consider an association between atrazine and
hypospadias.
Results: When controlling for maternal characteristics, any association between hypospadias and daily maternal atrazine
exposure during the critical window of genitourinary development was found to be weak or null (odds ratio for atrazine
in drinking water = 1. 00, 95 % CI = 0.97 to 1.03 per 0.04 μg/day increase; odds ratio for maternal consumption = 1.02,
95 % CI = 0.99 to 1.05; per 0.05 μg/day increase).
Conclusions: While the association that we observed was weak, our results suggest that additional research into a
possible association between atrazine and hypospadias occurrence, using a more sensitive exposure metric,
would be useful.
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Background
Hypospadias is a relatively common birth defect of the
male urinary tract, affecting between 4 to 6 of every
1,000 male births [1]. It occurs as a result of abnormal
urethral closure during gestational weeks 8–14, and
manifests with a urethral opening on the underside of
the penis [1]. It has a significant personal and public
health impact, as surgical repair is often needed to allow
for normal urinary and sexual function, and even after
correction, hypospadias may result in psychosocial and
sexual problems later in life [2].
Normal urethral closure during fetal development
depends upon binding of testosterone to the androgen
receptor and subsequent action by the androgen receptor
[1]. It has therefore been suggested that endocrine
disrupting chemicals might increase hypospadias risk [1].
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One potential endocrine disrupting chemical that has
been examined for an association with genitourinary
malformations is atrazine, one of the most widely used
agricultural herbicides in the United States [3]. It has been
suggested that atrazine may affect aromatase levels, and
by extension alter testosterone metabolism and sexual
differentiation in frogs [4, 5], and there is experimental
evidence to support a link between atrazine and genitouri-
nary malformations in both rats [6] and amphibians [4, 5,
7, 8]. These effects in animals may be analogous to some
of the key events that could lead to hypospadias in a de-
veloping fetus, providing biological plausibility for an asso-
ciation between exposure to atrazine and hypospadias.
The evidence to document a specific link between hypo-
spadias and atrazine in humans is somewhat equivocal,
however. Winchester et al. found an elevated prevalence
of “other urogenital anomalies,” but not of “malformed
genitalia” among infants conceived during months of the
highest concentrations of atrazine and other chemicals
measured by the US Geological Survey’s National Water
Quality Assessment Program [9]. Chevrier et al. examined
urinary biomarkers of atrazine and general male genital
anomalies. They found an increase in male genital anom-
alies among mothers with quantifiable atrazine or atrazine
metabolites in urine, but their sample size was very small
(5 cases exposed and 18 case unexposed) [10]. Only two
published studies to date have looked specifically at atra-
zine and hypospadias in humans, and they found mixed
results. The first study, by Meyer et al., assigned maternal
exposure to several agricultural pesticides (including atra-
zine) by estimating the amount of pesticides applied
within a 500–meter buffer of the mother’s home. They did
not find evidence of an association between hypospadias
and atrazine [11]. The second study, by Agopian et al.,
used Texas birth defects registry data and assigned atra-
zine levels to mothers based on their county of residence
at birth. They found some evidence of an increased risk of
second or third degree hypospadias for mothers in the
25th–75th percentiles of exposure (odds ratio = 1.52; CI =
1.25–1.85) and for the 75th–90th percentiles of expos-
ure (odds ratio = 1.44; CI = 1.11–1.85), but suggested
that further research was needed to confirm the
mechanism for an association between hypospadias
and county level atrazine use [12].
In this study, we seek to build on existing research
examining the potential relationship between atrazine
and hypospadias by incorporating information about
maternal water consumption, as well as other known
demographic and behavioral risk factors. We use a novel
technique to estimate maternal exposure to atrazine in
drinking water, and take advantage of unique data that
include information about behavioral covariates to con-
trol for confounding and maternal residential address
throughout pregnancy to improve exposure assessment.
Methods
Study population
Data from this study come from the National Birth
Defects Prevention Study (NBDPS), a population-based
case-control study conducted in ten states with the Cen-
ters for Disease Control and Prevention. NBDPS identi-
fies second- and third-degree hypospadias cases, which
are considered moderate to severe [1], from birth defect
surveillance registries and randomly selects controls
from birth certificates or birth hospital records. NBDPS
does not include first-degree, or mild, hypospadias cases
due to variable diagnosis patterns and medical documen-
tation. NBDPS cases were contributed by each center
(an active surveillance birth defects registry), and
reviewed by a clinical geneticist there to ensure that all
cases met NBDPS study criteria and thus ensure accur-
ate and consistent case ascertainment across study sites.
Second- and third- degree cases of hypospadias from all
centers were then reviewed in detail by a clinical geneticist
who focused on this birth defect, and who considered
medical record information and anatomical descriptions
provided by health care providers [13].
NBDPS also collects data on a wide number of covari-
ates via computer-assisted telephone interview with the
mother. For the years included in the study, the interview
also included a water module which asked questions about
drinking water source and water consumption. Additional
covariates include maternal address throughout preg-
nancy, and a number of known risk factors for hypospa-
dias, including maternal age, maternal race/ethnicity,
parity, plurality, maternal choline intake, and use of
fertility medications [14].
The study included hypospadias cases (n = 343, of
which 305 were isolated cases where hypospadias was
the only observed anomaly, and 38 were cases where
other birth defects were observed in conjunction with
hypospadias) and male controls (n = 1,422) whose
mothers were successfully interviewed from North
Carolina, Iowa, Arkansas, and Texas. Iowa, Arkansas,
and Texas contributed data for women with estimated
due dates between 1998 and 2005. North Carolina did
not join the study until 2003, providing data for women
with estimated due dates between 2003 and 2005. Ana-
lyses were conducted on isolated and non-isolated cases
combined. Among cases identified in the clinical database,
participation rates in the full interview were 73 % for Ar-
kansas, 44 % for Iowa, 73 % for North Carolina, and 65 %
for Texas. Participation rates for the male and female con-
trol groups were 67 % for Arkansas, 63 % for Iowa, 72 %
for North Carolina, and 64 % for Texas.
The 4 states were selected from the NBDPS study sites
because any association between atrazine and hypospadias
was predicted to be small, and atrazine concentrations in
streams were predicted to be higher in Iowa, Arkansas,
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Texas, and North Carolina than in other study sites [15].
The time period was selected because data were collected
for water consumption during this time.
Atrazine exposure estimation
We estimated atrazine concentrations using two United
States Geological Survey (USGS) models [3, 16]. Because
many public water supplies treat their raw water with
various filtration processes that will reduce concentra-
tions of atrazine, these models overestimate atrazine in
drinking water. We selected this approach, however,
because the models allowed us to consider a full range
of atrazine concentrations, and monitoring data were
not available for concentrations falling below the US En-
vironmental Protection Agency’s maximum contaminant
level of 3 μg/L.
We assigned atrazine concentrations to public water
supplies based on the type and location of the water in-
takes for each utility. Geographic coordinates of surface
and groundwater intakes for public water utilities were
available for Iowa, Texas, and North Carolina [17–20].
For Arkansas, we used Google Earth to geocode water
intakes using descriptions of intake locations available
from the Arkansas Department of Health [21]. For water
supplies using surface water, we used estimated annual
mean atrazine concentrations in streams predicted by
the Watershed Regressions for Pesticides (WARP) model
[16]. WARP uses estimated watershed-level atrazine use,
the percentage of the watershed’s agricultural land with
a soil restrictive layer near the surface, total precipitation
during May and June of the sampling year, rainfall
erosivity for the watershed, and streamflow caused by
precipitation on saturated soil in order to generate na-
tionwide estimates of atrazine concentrations in streams.
We used WARP estimates from the nearest stream
reach to assign an annual mean atrazine concentration
to public water intakes.
For water supplies using groundwater, we used site-
variable model predictions from the “Regression Models
for Estimating Concentrations of Atrazine plus Deethy-
latrazine in Shallow Groundwater in Agricultural Areas
of the United States” [3]. This model uses groundwater
residence time, atrazine use intensity, artificial drainage
practices, depth to the seasonally high water-table, con-
tent of the uppermost soil content, soil permeability,
groundwater recharge rates, and well depth to provide
gridded estimates of atrazine concentrations in shallow
groundwater. For groundwater intakes, and for mothers
in NBDPS using private wells, we used gridded atrazine
predictions from the USGS groundwater model and bi-
linear interpolation to estimate atrazine concentrations
based on the grid cell where the intake was located and
the adjacent grid cells.
Each public water utility was then assigned an atrazine
concentration equal to the mean of the predicted atra-
zine concentrations for all of the intakes for that utility.
Geographic assignment was conducted using ArcGIS
version 10.2 (ESRI Inc., Redlands, CA, USA).
Exposure assignment to study participants
We based our exposure assessment on maternal residen-
tial addresses during weeks 6–16 postconception, which
encompass the critical period for urethral development
[22]. Mothers using a public water supply were assigned
a water utility for each reported residential address by
the University of Iowa Center for Health Effects of
Environmental Contamination (CHEEC), using public
water supply service area polygons where available, and
Census place names and borders where service area
polygons were unavailable. They were then assigned an
atrazine concentration based on the amount of atrazine
estimated by the USGS models for that utility. Mothers
who reported using well water were assigned an atrazine
concentration using the same method as the ground-
water intakes. Mothers with more than one residential
address during the critical exposure period were
assigned a weighted value based on the atrazine concen-
tration and the number of weeks at each address. We
excluded mothers without a full residential history,
mothers using public water who were not successfully
matched to a public water utility, and mothers using a
utility that was not successfully assigned an atrazine
concentration by one of the two USGS models. This
reduced our sample size to 123 cases (35.9 % of the
original sample) and 415 controls (29.2 % of original
sample). We examined distributions across covariates for
those excluded to help characterize any selection bias
that might be introduced by these exclusions.
We then estimated the daily amount of atrazine con-
sumed via drinking water by a mother by multiplying
the estimated atrazine concentration in a mother’s raw
water supply by the self-reported amount of water
consumed daily by the mother. The self-reported num-
ber of glasses consumed ranged from 0 to 24 8-oz
glasses of water daily. Because it is unlikely that preg-
nant women are consuming no water, we converted the
women who reported drinking 0 glasses to missing and
excluded from further analyses. We then multiplied the
number of 8-ounce glasses by 0.237 to convert to liters
and estimate a total consumption in micrograms.
The distributions of maternal socioeconomic, demo-
graphic, and behavioral characteristics and hypospadias
cases and controls were examined. We used multivari-
able logistic regression analysis to estimate the odds ra-
tio for a hypospadias birth using two exposure measures
of interest: estimated concentration of atrazine in a
mother’s raw water supply and estimated daily maternal
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atrazine consumption. We estimated crude and adjusted
odds ratios for hypospadias for each exposure measure.
We estimated odds ratios stratified by state, and then es-
timated an overall odds ratio using a random effects
model with state as the group variable. Covariates used
for adjustment were selected based on existing literature,
and included private well use (yes, no), residential use of
water filtration (yes, no), state of residence (North Caro-
lina, Iowa, Arkansas, Texas), maternal age (14–19, 20–
24, 25–29, 30–34, 35–39, and over 40), maternal race/
ethnicity (non-Hispanic white, non-Hispanic black, His-
panic, and other), multiple or singleton birth, previous
pregnancies (yes, no), maternal education (less than high
school, high school, or more than high school), maternal
diabetes (yes, no), maternal high blood pressure (yes,
no), maternal body mass index (BMI) (less than 18.5,
18.5–25, 25–30, and over 30), choline use (less than
187.4 mg, 187.4–249.6 mg, 249.6–336.4 mg, and greater
than 336.4 mg, consistent with Carmichael et al. [14]),
and use of artificial reproductive technology (yes, no).
Analyses were performed using Stata version 13.1 (Stata-
Corp LP, College Station, TX, USA).
Results and Discussion
Distributions of demographic characteristics (state of
residence, age, multiple or singleton birth, previous
pregnancy, and education), behavioral characteristics
(use of private wells, water filtration, choline, and artifi-
cial reproductive technology), and health characteristics
(BMI, diabetes, and high blood pressure), for mothers of
hypospadias cases (n = 123) and mothers of male con-
trols (n = 415) are presented in Table 1. Mothers of cases
were more likely to be non-Hispanic white, more highly
educated, and to have used fertility medications or pro-
cedures, and infants with hypospadias were more likely
to be a result of a first pregnancy or a multiple birth.
Mothers of cases were slightly more likely to report
drinking 5 or more glasses of water a day. While con-
trols were fairly evenly distributed amongst the 4 states,
79.6 % of cases lived in Arkansas and North Carolina,
which is likely to be due to enrollment processes for
NBDPS [13]. No significant differences in distributions
were observed for reported use of a private well, residen-
tial use of water filtration, maternal age, maternal BMI,
maternal diabetes, maternal high blood pressure, or
maternal choline intake.
Raw distributions for estimated concentrations of atra-
zine for a mother’s water supply and for estimated daily
atrazine consumption are presented in Table 2. When
combining the data across all 4 states, mean and median
concentrations were higher for controls than for cases
for both estimated atrazine in water supply and esti-
mated atrazine consumption. In addition, the mean was
greater than the median for all estimates. We observed
differences in this trend when the data were stratified by
state. Specifically, this skewness may be due in part by
the small number of cases in Iowa and Texas, which also
had the highest concentrations of atrazine. Mean and
median concentrations were similar for both cases and
controls in North Carolina and Arkansas. The differ-
ence among states was greater for the estimated atra-
zine consumption because a small number of mothers
consumed a large amount of water. In all states, the
mean and median estimated atrazine in water supply
was well below the EPA’s maximum contaminant level
of 3 μg/L.
Table 3 presents odds ratios for the interquartile range
of exposure, reporting the increase or decrease in the
odds of having a baby with hypospadias associated with
an increase in atrazine concentration equal to the differ-
ence of the 75th and 25th percentiles of estimated
exposure. For Arkansas and Texas, the unadjusted and
adjusted odds ratios for the interquartile range of
estimated concentration of atrazine in a mother’s water
supply and a mother’s estimated daily atrazine consump-
tion were elevated. Odds ratios for Iowa and North
Carolina were below 1.0, but statewide estimates were
relatively imprecise as evidenced by the wide confidence
intervals (Table 3).
The crude odds ratios for estimated atrazine in water
supply and atrazine consumption, without stratification
by state, were close to 1.0. After adjustment for multiple
covariates the odds ratios for consumption were slightly
increased above the null for the interquartile range of
exposure.
Sensitivity analyses compared characteristics of
women who were successfully assigned an atrazine
exposure and women who were not successfully
assigned an atrazine exposure. These analyses suggest
that mothers who were excluded from the USGS
metric were less likely to be mothers of hypospadias
cases, less likely to use untreated water from private
wells, more likely to live in Arkansas, more likely to
be under age 30, and more likely to have a BMI
under 18.5 or greater than 25. The mothers excluded
from the metric were also more likely to identify as
non-Hispanic white or non-Hispanic black. See
Additional file 1 for additional information.
Conclusions
After adjusting for maternal socioeconomic, demo-
graphic, and behavioral characteristics, we observed a
weak association between hypospadias and maternal
consumption of atrazine via drinking water during gesta-
tional weeks 6–16 in overall models. This was a slightly
stronger association than that found by Meyer et al.
[11], but a much weaker association than that found by
Agopian et al. [12]. No association was observed in
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crude odds ratios, or when not accounting for the total
amount of drinking water consumed. In state-level
models, positive associations were observed in Arkansas
and Texas, while the opposite trend was observed in
North Carolina and Iowa.
Certain limitations should be considered when inter-
preting these results. While the USGS models that we
employed allowed us to estimate atrazine concentrations
in raw water supplies, they do not account for treatment
at public water supplies. Water treatment practices may
vary geographically, atrazine concentrations may vary
seasonally, and the USGS models do not capture this geo-
graphic or temporal variation. In addition, other contami-
nants which we were unable to measure or estimate,
particularly agricultural byproducts, may be correlated
with atrazine in water supplies.
We did consider other exposure estimation techniques,
first using monitoring data from the US Environmental
Protection Agency, and then using the amount of atrazine
applied at the county level. Both of these alternatives
proved problematic. Monitoring data were not available
for atrazine concentrations below the US Environmental
Protection Agency’s Maximum Contaminant Level, which
Table 1 Characteristics of NBDPS hypospadias cases and
controls with estimated atrazine exposure, 1998-2005
Cases Controls
Characteristic N % Missing N % Missing
Demographic characteristics
State of residence ** 0 0
Arkansas 49 39.8 85 20.5
Iowa 17 13.8 103 24.8
Texas 8 6.5 101 24.3
North Carolina 49 39.8 126 30.4
Maternal age 0 0
<20 10 8.1 43 10.4
20-24 27 22.0 89 21.5
25-29 25 20.3 118 28.4
30-34 42 34.2 105 25.3
≥35 19 15.5 60 14.5
Maternal race/ethnicity** 0 0
Non-Hispanic white 94 76.4 242 58.3
Non-Hispanic black 16 13.0 32 7.7
Hispanic 8 6.5 106 25.5
Other 5 4.1 35 8.4
Maternal education** 0 0
<High school 5 4.1 86 20.7
High school 30 24.4 111 26.8
>High school 88 71.5 218 52.5
Previous pregnancies** 0 0
No 55 44.7 122 29.4
Yes 68 55.3 293 70.6
Plurality* 0 0
Singleton birth 114 92.7 405 97.6
Multiple birth 9 7.3 10 2.4
Behavioral characteristics
Private well use 2 9
No 85 70.3 292 71.9
Yes 36 29.7 114 28.1
Reported water consumption+ 0 0
0 glasses 3 2.4 22 5.3
1-4 glasses 77 62.6 217 52.3
5 or more glasses 43 35.0 176 42.4
Residential filtered tap water 2 9
No 84 69.4 304 74.9
Yes 37 30.6 102 25.1
Table 1 Characteristics of NBDPS hypospadias cases and
controls with estimated atrazine exposure, 1998-2005
(Continued)
Maternal choline intakea 0 0
<187.4 mg 27 22.0 72 17.4
187.4 – 249.6 mg 30 24.4 85 20.5
249.7 – 336.3 mg 34 27.6 104 25.1
>336.4 mg 32 26.0 154 37.1
Fertility medications or
procedures*
0 4
No 111 90.2 393 95.6
Yes 12 9.8 18 4.4
Health characteristics
Diabetes 0 1
No 115 93.5 374 90.3
Yes 8 6.5 40 9.7
High blood pressure 0 0
No 95 77.2 344 92.9
Yes 28 22.8 71 17.1
Maternal BMI 1 22
<18.5 6 4.9 20 5.1
18.5-25 59 48.4 210 53.4
25-30 25 20.5 84 21.4
>30 32 26.2 79 20.1
+p < 0.1
*p < 0.05
**p < 0.01
aCategories for maternal choline intake from Carmichael et al. [14]
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Table 2 Distribution of estimated atrazine in water supply and estimated atrazine consumption
Cases Controls
Mean Median IQR Min, Max Mean Median IQR Min, Max
Estimated atrazine in water supply in AR, IA, TX, and NC (μg/L) 0.09 0.02 0.001–0.04 0.0001, 2.0 0.17 0.02 0.002–0.05 0.0001, 4.0
Arkansas 0.03 0.02 0.0004–0.03 0.00009, 0.31 0.02 0.02 0.005–0.03 0.0001, 0.31
Iowa 0.28 0.05 0.001–0.53 0.001, 0.95 0.47 0.45 0.002–0.66 0.0004, 4.02
North Carolina 0.02 0.02 0.0006–0.04 0.0002, 0.07 0.03 0.03 0.001–0.04 0.0002, 0.06
Texas 0.50 0.004 0.0004–0.99 0.0001, 1.98 0.17 0.005 0.001–0.13 0.0001, 3.94
Estimated atrazine consumption in AR, IA, TX, and NC (μg/day) 0.12 0.02 0.001–0.04 0.00004–3.75 0.14 0.02 0.002–0.06 0.00007–4.66
Arkansas 0.03 0.02 0.01–0.03 0.00004–0.22 0.02 0.01 0.003–0.03 0.00009–0.22
Iowa 0.29 0.06 0.001–0.47 0.0006–1.35 0.36 0.08 0.002–0.54 0.0002–2.86
North Carolina 0.02 0.01 0.0005–0.03 0.00008–0.08 0.03 0.02 0.001–0.05 0.0001–0.16
Texas 1.00 0.002 0.0004–3.28 0.0001–3.75 0.18 0.01 0.002–0.09 0.00007–4.66
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prevented us from considering associations between hypo-
spadias and lower levels of atrazine. Further, the total
amount of atrazine applied at the county level would not
have allowed us to consider the interaction between atra-
zine concentrations in water supplies and maternal water
consumption. The USGS water models allowed us to
estimate atrazine concentrations for private wells, which
are not regulated by the EPA, and for individual water
supplies with atrazine concentrations below the EPA’s
Maximum Contaminant Level.
We cannot be sure that our models accurately predict
maternal exposure to atrazine without a validated, re-
peated measure of atrazine in maternal urine during
pregnancy, and the lack of more reliable data on atrazine
exposure undoubtedly led to some misclassification
when assigning maternal exposure status. Our exposure
estimates also relied on self-reported water consump-
tion, which may be prone to recall bias. Assuming that
atrazine concentration misclassification and recall bias
was largely random between case and control mothers,
the results would have tended to be biased toward the
null, although this does not guarantee that our estimate
is an underestimate [23]. While our exposure estimates
therefore should not be used in a quantitative risk as-
sessment, the continuous nature of our estimated expos-
ure may be less prone to misclassification than a binary
exposure variable and useful for hypothesis generation.
Another limitation was our inability to assign atrazine
concentrations to many of the NBDPS women. Sensitivity
analyses revealed that women who were not successfully
assigned an atrazine concentration were more likely to live
in Arkansas, which was associated with increased risk in
this study. Women who were not successfully assigned an
exposure were also more likely to be non-Hispanic white
or non-Hispanic black, which were characteristics associ-
ated with decreased hypospadias risk in this study. They
were also less likely to use private wells, more likely to be
under age 30, and more likely to have a BMI under 18.5
or greater than 25, which were characteristics that were
not associated with hypospadias risk in this study. In
addition, a number of women were identified by state cen-
ters as eligible cases or controls, but were not successfully
interviewed. It is therefore unclear how exclusion of these
women may have influenced our results. Finally, some of
the odds ratio estimates were based on smaller sample
sizes and were imprecise.
This study also had several strengths. While other
studies have looked at proximity to pesticide application,
our modeled exposure estimates allowed us to consider
exposure via drinking water as a potential mechanism
for a possible association between atrazine and hypospa-
dias. It also took advantage of the unique water con-
sumption and other covariate data available through the
National Birth Defects Prevention Study (NBDPS),
which allowed us to improve our exposure assessment
and control for confounding.
A further strength of this study was that all of the
hypospadias cases were ascertained by population-based
birth defect surveillance systems, and underwent a de-
tailed clinical review and classification prior to inclusion
in the study. Cases with known genetic or chromosomal
abnormalities were excluded. This resulted in a more
etiologically and pathogenically homogenous case group.
Our models of maternal consumption of atrazine via
drinking water (OR 1.02 (95 % CI 0.99-1.05)) may provide
limited support for the hypothesis that atrazine may be
Table 3 Association between atrazine and hypospadias in the National Birth Defects Prevention Study, 1998–2005
N (cases) IQR Crude OR Adjusted ORb
State level models for estimated atrazine in water supply
Arkansas 134 (49) 0.02 1.05 (0.88, 1.26) 1.02 (0.80, 1.24)
Iowa 120 (17) 0.63 0.64 (0.28, 1.42) 0.66 (0.26, 1.67)
North Carolina 175 (49) 0.003 0.97 (0.92–1.02) 0.97 (0.88, 1.08)
Texas 109 (8) 0.13 1.09 (0.97, 1.22) 1.22 (1.01, 1.48)
State level models for estimated atrazine consumption
Arkansas 131 (49) 0.03 1.06 (0.83, 1.35) 1.40 (0.34, 5.78)
Iowa 106 (16) 0.54 0.85 (0.46, 1.57) 0.46 (0.02, 11.9)
North Carolina 171 (48) 0.05 0.50 (0.27, 0.91) 0.02 (0.00, 1.24)
Texas 105 (7) 0.09 1.07 (1.01, 1.12) 1.93 (1.02, 3.23)
Estimated atrazine in water supply across statesa 538 (123) 0.04 0.97 (0.94, 1.00) 1. 00 (0.97, 1.03)
Estimated atrazine consumption across statesa 513 (120) 0.05 0.99 (0.96 1.02) 1.02 (0.99, 1.05)
aAll ORs reported for interquartile range, or an increase from the in atrazine concentration equal to the difference of the 75th and 25th percentiles
bORs for random effects models using state as the group variable. Random effects models and models for Arkansas, Iowa, and North Carolina adjusted by private
well use, residential use of filtered water, maternal age, maternal race/ethnicity, plurality, parity, maternal education, choline use, use of artificial reproductive
technology, maternal diabetes, maternal high blood pressure, and maternal BMI. Models for Texas adjusted by only private well use, maternal age, maternal race/
ethnicity, parity, maternal education, choline use, and maternal high blood pressure because of the small number of cases
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associated with male genitourinary malformations in
humans, although we could not exclude the possibility of a
null association, given the limitations described above. Our
results are not intended to be used in lieu of an exposure
risk assessment, but rather to generate hypotheses about
the trends and patterns of associations between atrazine
and hypospadias. Further research including a larger sam-
ple size and better exposure characterization would be use-
ful to provide a more definitive characterization of the
potential effects of atrazine.
Additional file
Additional file 1: Characteristics of women successfully assigned an
atrazine exposure and women who were not successfully assigned an
atrazine exposure. (DOCX 19 kb)
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